Key Market Indicators
Latvian analgesic medicine sales are expected to hit $14.1 million by 2026. In 2021, the market was valued at $13 million, a 1.9% year-on-year increase. Since 2006, sales have grown at an average rate of 7.9% annually. Latvia was 21st in the global ranking of analgesic medicine sales in 2021, behind Hungary at $13 million. Spain, Canada and Italy were the top three countries in the ranking.
